StockData
Vericel Corp logo

Vericel Corp (VCEL) stock

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$57.88+0.40 (+0.70%)

Close on Nov 17, 2026Market cap $2.96BP/E 137.8Yield –

Vericel revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Vericel's revenue for the twelve months ending Jun 30, 2026 was $306.30M, up 23.0% year over year. For fiscal 2025 it was $276.26M, up 16.5% from the year before. Over ten years it grew 18.4% a year on average. The highest annual figure on record is $276.26M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$276.26M+16.5%
FY2024Dec 31, 2024$237.22M+20.1%
FY2023Dec 31, 2023$197.52M+20.2%
FY2022Dec 31, 2022$164.37M+5.2%
FY2021Dec 31, 2021$156.18M+25.8%
FY2020Dec 31, 2020$124.18M+5.4%
FY2019Dec 31, 2019$117.85M+29.7%
FY2018Dec 31, 2018$90.86M+42.1%
FY2017Dec 31, 2017$63.92M+17.5%
FY2016Dec 31, 2016$54.38M+6.3%
FY2015Dec 31, 2015$51.17M+77.7%
FY2014Dec 31, 2014$28.80M+151457.9%
FY2013Dec 31, 2013$19.00K-9.5%
FY2012Dec 31, 2012$21.00K-76.4%
FY2010Jun 30, 2010$89.00K-51.1%
FY2009Jun 30, 2009$182.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$77.46M+22.5%
Q1 FY2026Mar 31, 2026$68.43M+30.1%
Q4 FY2025Dec 31, 2025$92.92M+23.3%
Q3 FY2025Sep 30, 2025$67.50M+16.6%
Q2 FY2025Jun 30, 2025$63.24M+20.1%
Q1 FY2025Mar 31, 2025$52.60M+2.6%
Q4 FY2024Dec 31, 2024$75.38M+16.0%
Q3 FY2024Sep 30, 2024$57.91M+27.0%
Q2 FY2024Jun 30, 2024$52.66M+14.7%
Q1 FY2024Mar 31, 2024$51.28M+25.0%
Q4 FY2023Dec 31, 2023$65.00M+23.3%
Q3 FY2023Sep 30, 2023$45.58M+18.2%
Q2 FY2023Jun 30, 2023$45.92M+24.0%
Q1 FY2023Mar 31, 2023$41.02M+13.7%
Q4 FY2022Dec 31, 2022$52.69M+10.7%
Q3 FY2022Sep 30, 2022$38.55M+11.7%
Q2 FY2022Jun 30, 2022$37.05M-6.3%
Q1 FY2022Mar 31, 2022$36.07M+4.4%
Q4 FY2021Dec 31, 2021$47.59M+5.2%
Q3 FY2021Sep 30, 2021$34.51M+7.0%
Q2 FY2021Jun 30, 2021$39.52M+97.5%
Q1 FY2021Mar 31, 2021$34.57M+29.6%
Q4 FY2020Dec 31, 2020$45.23M+14.8%
Q3 FY2020Sep 30, 2020$32.26M+5.8%
Q2 FY2020Jun 30, 2020$20.01M-23.5%
Q1 FY2020Mar 31, 2020$26.68M+22.3%
Q4 FY2019Dec 31, 2019$39.39M+25.7%
Q3 FY2019Sep 30, 2019$30.50M+35.6%
Q2 FY2019Jun 30, 2019$26.15M+37.6%
Q1 FY2019Mar 31, 2019$21.81M+21.0%
Q4 FY2018Dec 31, 2018$31.34M+34.2%
Q3 FY2018Sep 30, 2018$22.48M+57.7%
Q2 FY2018Jun 30, 2018$19.01M+12.1%
Q1 FY2018Mar 31, 2018$18.03M+92.6%
Q4 FY2017Dec 31, 2017$23.35M0.0%
Q3 FY2017Sep 30, 2017$14.26M+30.5%
Q2 FY2017Jun 30, 2017$16.95M–
Q1 FY2017Mar 31, 2017$9.36M–
Q4 FY2016Dec 31, 2016$23.35M–
Q3 FY2016Sep 30, 2016$10.93M–

More Vericel figures

See a number that looks wrong?